The doctor may suggest some other medicine which could be more effective in treating your diabetes. For some people, taking metformin alone can effectively lower blood sugar levels. But, evidence ...

New research found that Dapagliflozin reduces the relative and absolute risk of death and heart failure-related ...

Share on Pinterest New research shows that metformin may help slow down aging in certain organs, at least in monkeys. Scott Olson/Getty Images In a new study conducted in cynomolgus monkeys ...

Grant share is based on the ratio of number of grants to total number of patents. The granted patent US12071418B2 outlines a comprehensive process for the preparation of dapagliflozin, a medication ...

(2012) TIIDM female patients (n = 215) with HbA1c = 7.0–10.5% and inadequate glycemic control on metformin (12 weeks ... and urinary tract infections. Dapagliflozin is the first agent of ...

Metformin has long been the cornerstone of therapy for glycemic control in patients with Type 2 diabetes worldwide. It is recommended as first-line therapy by all major diabetes clinical practice ...

The "Type 2 Diabetes in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ResearchAndMarkets.com's offering. This report provides a ...

SGLT2 inhibitors and dulaglutide are associated with comparable risk for dementia; however, it is uncertain whether these findings generalize to newer GLP-1 RAs.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Global data from WHO demonstrate a significant disproportionality for semaglutide and suicidal ideation compared with all medications.